Sign in

You're signed outSign in or to get full access.

James Cassano

Director at DNA XDNA X
Board

About James Cassano

James Cassano has served on Sonim’s Board since July 2022 and is an independent director designated as an Audit Committee financial expert. He was 78 years old as of June 20, 2024. He holds a BS in Aeronautics and Astronautics from Purdue University and an MBA from Wharton. His background spans CFO roles, private equity, SPAC leadership, and founding and scaling technology and education businesses, providing deep financial oversight and M&A experience relevant to audit chair duties .

Past Roles

OrganizationRoleTenureCommittees/Impact
CoActive Health Solutions, LLCPartner & Chief Financial OfficerDec 2009 – Dec 2021Global CRO finance leadership; supports pharma/biotech clients
Jaguar Capital Partners / Jaguar Acquisition Corp (OTCBB: JGAC)Partner (Jaguar); EVP, CFO, Secretary & Director (Jaguar Acquisition SPAC)2005 – 2009SPAC formation and public company financial leadership
New Forum Publishers (sold to Apex Learning)Founder, Chairman & CEO1998 – Aug 2003 (consultant to Feb 2004)Built and exited edtech publisher to a Warburg Pincus–controlled company
Tickets.com (formerly Advantix, Inc.)Co‑founder (Advantix); company went public in 19991995 – 1999High‑volume e‑ticketing and payments platform; IPO outcome
Hill Group, Inc.SVP & Chief Financial OfficerMar 1987 – Jun 1995Finance leadership at engineering/consulting firm
Safeguard Scientifics, Inc.VP, Investments & AcquisitionsFeb 1986 – Mar 1987Venture development investing and M&A
Hay Associates (Europe)Partner & Director, Strategic Management ServicesMay 1973 – Feb 1986Strategy advisory leadership (Europe)

External Roles

OrganizationRoleTenureCommittees
Ideanomics, Inc.Vice Chairman & Lead Independent DirectorDirector since 2008 (current)Chair: Audit; Member: Compensation, Acquisition Oversight, Risk, Disclosure

Board Governance

  • Independence: Independent director under Nasdaq rules; Audit Committee financial expert designation .
  • Committees: Audit Committee Chair; Compensation Committee member .
  • Attendance: Each director attended at least 75% of combined Board and committee meetings in FY2023; 2023 Board met 5x; Audit 5x; Compensation 3x; Nominating & Governance 1x .
  • Board structure: Independent Chair (Mike Mulica); Board holds executive sessions of independent directors .
  • Related‑party oversight: Audit Committee reviews and ratifies related‑person transactions under a written policy; directors must recuse if interested .

Fixed Compensation

Item (Non‑Employee Director)2024 Amount (USD)
Annual Board cash retainer$35,000
Audit Committee Chair retainer$15,000
Compensation Committee member fee$5,000
Total fees earned in cash (Cassano)$55,000 (reported)
NotesCommittee fee schedule and base retainer per policy; Cassano’s reported cash total equals the sum of base + Audit Chair + Compensation member
  • Non‑executive Chair adders (not applicable to Cassano): +$50,000 cash retainer and +$50,000 RSU grant annually .

Performance Compensation

Grant TypeGrant DateShares/UnitsGrant‑date Fair ValueVestingChange of Control / Other
RSUs (annual grant)June 20, 20247,895 RSUs$60,000Vests in one installment on the earlier of first anniversary or immediately prior to 2025 annual meetingDirector RSUs fully vest upon change of control, death, or disability
  • Equity policy: New non‑employee directors receive an initial $60,000 RSU grant; annual RSU grants are $60,000 thereafter .
  • 2025 plan constraints: Following the 2025 annual meeting, share reserve was insufficient for standard RSU grants; the company used cash awards with vesting akin to RSUs for non‑employee directors pending share pool increase (affects structure/at‑risk mix) .

Other Directorships & Interlocks

CompanyOverlap TypePotential Interlock/Conflict
Ideanomics, Inc.External public directorship; Audit ChairNo Sonim related‑party transactions disclosed involving Cassano in the proxy’s related‑party section; Audit Committee oversees any such matters under policy .

Expertise & Qualifications

  • Financial expertise: Designated Audit Committee financial expert; extensive CFO and audit oversight experience in public company settings (SPAC, operating companies) .
  • M&A and capital markets: SPAC executive (Jaguar Acquisition Corp), private equity partner (Jaguar Capital Partners) .
  • Operating and governance breadth: Leadership roles across technology, edtech, engineering services; long‑tenured external public company director (Ideanomics) with multiple committee responsibilities .
  • Education: BS, Aeronautics & Astronautics (Purdue); MBA, Wharton School (UPenn) .

Equity Ownership

MetricMay 30, 2024Sept 15, 2025
Shares beneficially owned (Cassano)199,805 (includes 120,799 RSUs vesting within 60 days) 49,126 (less than 1%)
% of outstanding shares<1% (based on 46,717,887 outstanding) <1% (based on 17,781,919 outstanding)
  • Section 16 compliance: All officers and directors filed required reports on a timely basis for FY2023 (no delinquencies) .
  • Anti‑hedging: Company maintains a Code of Conduct and governance framework; governance documents are available on IR site; anti‑hedging policy referenced (no specific director pledging disclosure noted) .

Governance Assessment

  • Positives

    • Independent Audit Chair with “financial expert” designation and deep CFO/SPAC background enhances financial reporting oversight and risk management .
    • Solid engagement record: at least 75% attendance in FY2023 across Board/committees; Board structure includes independent chair and executive sessions .
    • Director pay is modest and balanced (2024: $55k cash, $60k equity), aligning incentives while recognizing committee workload (Audit Chair, Comp member) .
  • Watch items

    • Single‑trigger vesting for director RSUs upon change of control; while common for directors, investors may prefer double‑trigger structures for tighter alignment .
    • Equity plan permits repricing actions with participant consent, which some governance frameworks scrutinize; continuous board discipline is warranted .
    • Post‑2025 shift to cash‑settled awards due to limited share reserve reduces equity‑based alignment until the plan is replenished, though the company sought share increases to restore equity compensation .